Asymptomatic Leishmania infection: a new challenge for Leishmania control.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 24585564.
- Also identified by DOI 10.1093/cid/ciu102 and PMC identifier 4001287.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Visceral leishmaniasis (VL) is a serious parasitic disease, causing high morbidity and mortality in the developing world. The pathogenesis of VL is complex, and the clinical presentation ranges from asymptomatic infection to severe and fatal disease. Despite a wealth of research on the full-blown "clinical VL" syndrome, asymptomatic leishmania infections remain poorly understood. Asymptomatic infection could present a major challenge for control programs if its infectiousness is confirmed. In this viewpoint, we highlight the crucial knowledge gaps as well as the obstacles in research on asymptomatic leishmanial infection. Research in this area is essential for the development of more-effective VL control strategies.
Medical subject headings
- Asymptomatic Infections
- Leishmaniasis
- Leishmaniasis, Visceral